ALPRAZOLAM | A074342 | ACTAVIS ELIZABETH LLC AN INDIRECT WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INC
Highest NADAC/Unit
$0.0479
per ea
Lowest NADAC/Unit
$0.0225
per ea
Brand NDCs
0
Generic NDCs
10
| NDC Description | NADAC/Unit | Unit | Type | Generic NADAC | Effective |
|---|---|---|---|---|---|
| 00228203910ALPRAZOLAM 2 MG TABLET | $0.0479 | EA | Generic | — | 2026-06-17 |
| 00228202710ALPRAZOLAM 0.25 MG TABLET | $0.0248 | EA | Generic | — | 2026-06-17 |
| 00228202750ALPRAZOLAM 0.25 MG TABLET | $0.0248 | EA | Generic | — | 2026-06-17 |
| 00228202796ALPRAZOLAM 0.25 MG TABLET | $0.0248 | EA | Generic | — | 2026-06-17 |
| 00228203196ALPRAZOLAM 1 MG TABLET | $0.0246 | EA | Generic | — | 2026-06-17 |
| 00228203110ALPRAZOLAM 1 MG TABLET | $0.0246 | EA | Generic | — | 2026-06-17 |
Showing 6 of 10 NDCs.
Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.
No patent or exclusivity listings for this strength.